2013 American Transplant Congress
Lung Recipients with Post-Transplant Lung Cancer and Comparison with Other Organ Recipients
The burden and impact of lung cancer among transplant recipients and a comparison between recipients of lung and other organs has been studied in small…2013 American Transplant Congress
Sepsis after Renal Transplantation: Clinical, Microbiological, and Immunological Characteristics
As immunosuppressive drugs and allograft survival have improved over the last decades, infection has become the main hurdle of patient survival and long-term allograft function…2013 American Transplant Congress
New-Onset Diabetes and Glucose Regulation Are Significant Determinants of Left Ventricular Hypertrophy
Purpose: . Arterial stiffness has a pivotal role in the genesis of high blood pressure (SBP), increased left ventricular hypertrophy (LVH), and consequently CV mortality.…2013 American Transplant Congress
Health-Related Quality of Life in the Pre-Transplant Candidate Low MELD for End-Stage Liver Disease (MELD) Score: A Pilot Study
Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL
Cadaveric liver organ allocation is based on the model for end-stage liver disease (MELD) score. Those with low MELD scores (≤ 15) are considered to…2013 American Transplant Congress
Excellent Results of Living-Related Renal Transplant Recipients Treated with High-Dose Mizoribine – Two Years Result of a Japanese Multicenter Study
(Aims) Mizoribine (MZR) has been developed as an immunosuppressive agent, but has a less potent immunosuppressive effect up to 3 mg/kg/day. The widespread use of…2013 American Transplant Congress
Critical Analysis of Valganciclovir Dosing and Renal Function on the Development of CMV Infection in Kidney Transplantation
Purpose: To evaluate factors that impact the development of CMV infection in renal transplant recipients.Background: Cytomegalovirus (CMV) infection is one of the most common and…2013 American Transplant Congress
Behavior of ADAMTS13 and Von Willebrand Factor Levels in Patients after Living Donor Liver Transplantation
Introduction : Thrombotic microangiopathy (TMA) is one of the important complications occurring after liver transplantation (LT), and it is suggested that a Von Willebrand factor…2013 American Transplant Congress
Impact of Donor-Specific Anti-HLA and Anti-Angiotensin-II Type 1 Receptor Antibodies on Graft Fibrosis after Immunosuppression Withdrawal in Pediatric Liver Transplantation
Pediatric living-donor liver transplant (LDLT) recipients can often exhibit a reduction or cessation of immunosuppression (IS); over the long term, a high incidence of progressive…2013 American Transplant Congress
Combination of Anti-BTLA Antibody (6B2) and Anti-PD-1 Antibody (PIM-2) Induced Indefinite Survival of Fully MHC-Mismatched Murine Cardiac Allograft
Background: Programmed death (PD)-1 has been implicated in peripheral tolerance, and the coinhibitory receptor B and T lymphocyte attenuator (BTLA) has been implicated in the…2013 American Transplant Congress
What Is the Best Treatment for BK Viremia after Kidney Transplantation: Results of a 5-Year Screening Study
Purpose: Various anecdotal reports have described clinical activity of cidofovir, leflunomide, and ciprofloxacin in clearing the BK virus. Our aim was to define the factors…
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 178
- Next Page »